Cytogenetic analyses in acute myeloid leukemia (AML) and acute lymphoblastic leukemia
(ALL) have revealed a great number of non-random chromosome abnormalities. In many …

Cytogenetic analysis is the most important diagnostic tool for determining prognosis in acute
myeloid leukemia (AML). In the majority of patients with AML, acquired clonal chromosome …

Cytogenetic studies of acute myeloid leukemia (AML) have revealed that the majority of
patients display acquired chromosome aberrations. Numerous recurrent karyotypic …

During the last three decades it has become apparent that the majority of cases of acute
myeloid leukaemia (AML) are characterized by at least one of a variety of recurrent …

Acquired chromosome aberrations are present in the marrow of most patients with acute
myeloid leukaemia (AML) at diagnosis. Cytogenetically, AML is a very heterogeneous …

The last 4 decades have seen major advances in understanding the genetic basis of acute
myeloid leukemia (AML), paralleled by substantial improvements in survival of children and …

PURPOSE: To prospectively compare cytogenetic and molecular cytogenetic analysis for
the detection of the most relevant chromosome abnormalities in a large series of patients …

Using literature data on cytogenetic abnormalities in 3,612 cases of acute myeloid leukemia
(AML) and 1,551 cases of acute lymphocytic leukemia (ALL), we have attempted to quantify …

Acute lymphoblastic leukemia (ALL) is classified as B‐lineage ALL (B‐ALL) and T‐lineage
ALL (T‐ALL). The incidence of ALL is almost three times higher in white than black children …

Patients with acute myeloid leukemia (AML) harboring three or more acquired chromosome
aberrations in the absence of the prognostically favorable t (8; 21)(q22; q22), inv …